Feb 4 (Reuters) - In the first outlook presented by new CEO Luke Miels, GSK on Wednesday said it expected slower sales growth in 2026 compared with a year earlier, as it expands its pipeline to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results